Equitech International Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$541.52 | $591.94 | 12.00% | 1 | $208.89B |
| DHR | Danaher | Outperform |
10
|
$236.36 | $260.33 | 14.23% | 4 | $177.28B |
| A | Agilent Technologies | Outperform |
10
|
$132.44 | $138.82 | 14.39% | 10 | $39.43B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.19k | $1.12k | 3.14% | 0 | $25.62B |
| ILMN | Illumina | Outperform |
16
|
$116.69 | $159.28 | 29.47% | 9 | $18.84B |
| WAT | Waters | Hold |
15
|
$294.23 | $323.50 | 12.16% | 2 | $18.04B |
| AVTR | Avantor | Outperform |
16
|
$24.30 | $23.25 | 15.23% | 19 | $16.56B |
| PKI | PerkinElmer | Outperform |
16
|
$99.38 | $121.84 | 24.65% | 1 | $12.42B |
| BRKR | Bruker | Outperform |
16
|
$78.56 | $73.64 | 15.20% | 1 | $11.42B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$281.02 | $536.80 | 55.40% | 1 | $8.76B |
| COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.46 | $12.67 | 345.21% | 4 | $1.78B |
| LAB | Standard BioTools | Buy |
11
|
$2.54 | $4.00 | 37.80% | 1 | $686.85M |
| HBIO | Harvard Bioscience | Buy |
14
|
$4.09 | $7.00 | 71.15% | 2 | $191.82M |
| ENZ | Enzo Biochem | - |
8
|
$1.36 | $5.50 | -100.00% | 0 | $62.10M |
| DYXC | DiaSys | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.03M |
| ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |